Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 0 | 22 | 0 | 43 | 22 |
Gross Profit | N/A | 22 | 0 | 43 | 22 |
Operating Expenses | 71,431 | 69,526 | 85,130 | 63,018 | 80,562 |
Operating Income | -71,431 | -69,504 | -85,130 | -62,975 | -80,540 |
Other Income | 5,073 | 4,504 | -1,620 | 1,660 | 1,308 |
Pre-tax Income | -66,358 | -65,000 | -86,750 | -61,315 | -79,232 |
Net Income Continuous | -66,358 | -65,000 | -86,750 | -61,315 | -79,232 |
Net Income | $-66,358 | $-65,000 | $-86,750 | $-61,315 | $-79,232 |
EPS Basic Total Ops | -0.35 | -0.38 | -0.49 | -0.37 | -0.54 |
EPS Basic Continuous Ops | -0.35 | -0.38 | -0.49 | -0.37 | -0.54 |
EPS Diluted Total Ops | -0.35 | -0.38 | -0.49 | -0.37 | -0.54 |
EPS Diluted Continuous Ops | -0.35 | -0.38 | -0.49 | -0.37 | -0.54 |
EPS Diluted Before Non-Recurring Items | -0.32 | -0.38 | -0.43 | -0.37 | -0.53 |
EBITDA(a) | $-69,988 | $-68,746 | $-84,952 | $-62,347 | $-77,971 |